Resumen:
Leishmaniasis is a neglected tropical illness with a wide variety of clinical signs ranging
from visceral to cutaneous symptoms, resulting in millions of new cases and thousands of fatalities
reported annually. This article provides a bibliometric analysis of the main authors’ contributions,
institutions, and nations in terms of productivity, citations, and bibliographic linkages to the application
of nanoparticles (NPs) for the treatment of leishmania. The study is based on a sample of
524 Scopus documents from 1991 to 2022. Utilising the Bibliometrix R-Tool version 4.0 and VOSviewer
software, version 1.6.17 the analysis was developed. We identified crucial subjects associated with
the application of NPs in the field of antileishmanial development (NPs and drug formulation for
leishmaniasis treatment, animal models, and experiments). We selected research topics that were
out of date and oversaturated. Simultaneously, we proposed developing subjects based on multiple
analyses of the corpus of published scientific literature (title, abstract, and keywords). Finally, the
technique used contributed to the development of a broader and more specific “big picture” of
nanomedicine research in antileishmanial studies for future projects.
